scholarly journals Transverse maxillary and mandibular growth during and after Bionator therapy: study with metallic implants

2013 ◽  
Vol 18 (3) ◽  
pp. 72-79
Author(s):  
André da Costa Monini ◽  
Luiz Gonzaga Gandini Júnior ◽  
Luiz Guilherme Martins Maia ◽  
Ary dos Santos-Pinto

INTRODUCTION: This study evaluated posteroanterior cephalograms before and after treatment and long term follow-up of Class II division 1 patients treated with bionator. OBJECTIVE: The objective was to demonstrate the transverse growth of maxilla and mandible during and after bionator therapy. METHODS: Measurement of transverse dimensions between posterior maxillary and mandibular implants, as well as the distances between the buccal, gonial and antegonial points were recorded. Measurements were analyzed at three periods: T1 = before bionator therapy, T2 = after bionator therapy and T3 = 5.74 years after T2. RESULTS: There was statistically significant transverse increase due to growth and/or treatment for all variables, except for the distance between the anterior maxillary implants. CONCLUSIONS: During the study period only the anterior maxillary area did not show transverse growth.

2006 ◽  
Vol 76 (6) ◽  
pp. 930-941 ◽  
Author(s):  
Niko Bock ◽  
Hans Pancherz

Abstract Objective: The aim of this retrospective pilot study was to analyze and compare the short-term and long-term changes of Herbst treatment in Class II division 1 subjects of the retrognathic and prognathic facial type. Materials and Methods: The subject material comprised 10 retrognathic (mean SNA = 74.5°, SNB = 70.4°, ML/NSL = 41.1°) and 16 prognathic (mean SNA = 86.7°, SNB = 81.5°, ML/NSL = 25.1°) Class II division 1 subjects treated with the Herbst appliance for an average period of 7 months. Lateral head films from before (T1), immediately after (T2), 12 months after (T3), and 39 months after (T4) Herbst treatment were analyzed with the SO-analysis (analysis of changes in sagittal occlusion) and standard cephalometrics. Results: During the treatment period (T2–T1) the two facial type groups showed similar favorable changes for all variables. During the posttreatment periods of 12 months (T3–T2) and 39 months (T4–T2) recovering changes occurred. In the long-term, a tendency of more unfavorable growth changes was stronger (not significant) for retrognathic subjects than for prognathic subjects. Conclusion: On a long-term basis, retrognathic subjects are prone to exhibit more unfavorable mandibular growth changes than prognathic subjects and, thus, might exhibit a greater risk for an occlusal relapse when a stable Class I occlusion is not attained after treatment.


2019 ◽  
Vol 4 (2) ◽  
Author(s):  
Nugroho Ahmad Riyadi

The aim of orthodontics treatment is normalization of teeth position in three planes, using various orthodontics appliance to reach the chepalometric standar and normal occlusion. Orthodontic treatment for dentoskeletal class II division 1 malocclusion in growing patients using myofunctional appliance may correct anteroposterior planes of mandibula. This study was a descriptive retrospective analytic study to look at the success of Orthodontic treatment for dentoskeletal class II division 1 in growing patients with myofunctional appliance using chepalometrics analysis Steiner value. The sample used in this study is chepalogram radiographic from patient with dentoskeletal class II division 1 malocclusion in growing patients before and after using myofunctional appliance in PPDGS orthodontics Clinic of Padjadjaran University. Statistic analysis were performed with pair t-test and Wilcoxon. Based on this study, it is concluded that orthodontic treatment with myofunctional appliance such as activator and twin block in growing patient with dentoskeletal class II division 1 malocclusion shows significant changes and compatibility with the normal criteria.


2016 ◽  
Vol 27 (6) ◽  
pp. 523-527 ◽  
Author(s):  
Ana Cláudia M. Melo ◽  
Ingrid M. Ledra ◽  
Rogéria A. Vieira ◽  
Edivaldo R. Coró ◽  
Ivete Aparecida de M. Sartori

2019 ◽  
Vol 78 (11) ◽  
pp. 1497-1504 ◽  
Author(s):  
Debbie M Boeters ◽  
Leonie E Burgers ◽  
René EM Toes ◽  
Annette van der Helm-van Mil

ObjectivesSustained disease-modifying antirheumatic drug (DMARD)-free status, the sustained absence of synovitis after cessation of DMARD therapy, is infrequent in autoantibody-positive rheumatoid arthritis (RA), but approximates cure (ie, disappearance of signs and symptoms). It was recently suggested that immunological remission, defined as disappearance of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF), underlies this outcome. Therefore, this long-term observational study determined if autoantibodies disappear in RA patients who achieved sustained DMARD-free remission.MethodsWe studied 95 ACPA-positive and/or RF-positive RA patients who achieved DMARD-free remission after median 4.8 years and kept this status for the remaining follow-up (median 4.2 years). Additionally, 21 autoantibody-positive RA patients with a late flare, defined as recurrence of clinical synovitis after a DMARD-free status of ≥1 year, and 45 autoantibody-positive RA patients who were unable to stop DMARD therapy (during median 10 years) were studied. Anti-cyclic citrullinated peptide 2 (anti-CCP2) IgG, IgM and RF IgM levels were measured in 587 samples obtained at diagnosis, before and after achieving DMARD-free remission.Results13% of anti-CCP2 IgG-positive RA patients had seroreverted when achieving remission. In RA patients with a flare and persistent disease this was 8% and 6%, respectively (p=0.63). For anti-CCP2 IgM and RF IgM, similar results were observed. Evaluating the estimated slope of serially measured levels revealed that RF levels decreased more in patients with than without remission (p<0.001); the course of anti-CCP2 levels was not different (p=0.66).ConclusionsSustained DMARD-free status in autoantibody-positive RA was not paralleled by an increased frequency of reversion to autoantibody negativity. This form of immunological remission may therefore not be a treatment target in patients with classified RA.


2020 ◽  
Vol 45 (7) ◽  
pp. 715-721
Author(s):  
Marie Le Mapihan ◽  
Alina Badina ◽  
Stéphanie Pannier ◽  
Arielle Salon ◽  
Chrisophe Glorion ◽  
...  

In Rubinstein–Taybi syndrome, patients may have a particularly severe clinodactyly of the thumb. We evaluated a new method for correction of these severe clinodactylies using non-vascularized toe phalanx transfer as a replacement for the abnormal delta phalanx. Results of the new technique are presented, together with those of an osteotomy technique. We retrospectively recorded the angle of the clinodactyly before and after surgery and at long-term follow-up of 11 osteotomies and five transfers in nine patients from 1990 to 2017. The pre-operative angle of clinodactyli was similar between the two groups with a mean of 59°. After surgery, the correction was equivalent (7° and 11°). At the last follow-up (7 and 18 years), the relapse of clinodactyly was 17° for osteotomies and 1° for phalanx transfers. We noticed growth of the transferred phalanx, resulting in an excellent thumb length. We conclude that non-vascularized toe transfer can be an effective correction of severe clinodactyly and may be more stable than osteotomy in the long-term. Level of evidence: IV


2014 ◽  
Vol 38 (4) ◽  
pp. 380-384 ◽  
Author(s):  
E A Satygo ◽  
A V Silin ◽  
G O Ramirez-Yañez

Objective: A study was designed to determine changes in the amplitude of the EMG muscular activity of the Masseter and Temporalis muscles at clench in children with a Class II, division 1 malocclusion treated with the pre-orthodontic Trainer functional appliance, for 12 months. Study Design: 36 Class II, division 1 malocclusion patients (mean age 7.6 ± 1.3 years) composed the treated group and wore the functional appliance; 22 children with a similar age and malocclusion composed the untreated controls; and, 20 children with no dental malocclusion participated as normal controls. Electromyographic (EMG) muscular activity of the Temporalis and Masseter muscles were recorded before and after treatment. Results: Subjects in the treated group reported a bilateral significant increase in the muscular electrical activity in the both tested muscles (p &lt; 0.001). After treatment, they recorded values similar to those measured in normal controls, whereas the untreated controls remained on lower values. Conclusion: These results confirm that treatment with the pre-orthodontic Trainer functional appliance significantly increases the EMG muscular activity in the Temporalis and Masseter muscles at clench in patients with Class II, division 1 malocclusion.


2013 ◽  
Vol 18 (4) ◽  
pp. 70-81
Author(s):  
Osama Hasan Alali

INTRODUCTION: This article demonstrates the description and use of a new appliance for Class II correction. MATERIAL AND METHODS: A case report of a 10-year 5 month-old girl who presented with a skeletally-based Class II division 1 malocclusion (ANB = 6.5º) on a slightly low-angle pattern, with ML-NSL angle of 30º and ML-NL angle of 22.5º. Overjet was increased (7 mm) and associated with a deep bite. RESULTS: Overjet and overbite reduction was undertaken with the new appliance, Fixed Lingual Mandibular Growth Modificator (FLMGM). CONCLUSION: FLMGM may be effective in stimulating the growth of the mandible and correcting skeletal Class II malocclusions. Clinicians can benefit from the unique clinical advantages that FLMGM provides, such as easy handling and full integration with bracketed appliance at any phase.


Sign in / Sign up

Export Citation Format

Share Document